P140 DYNAMIC COMPRESSION COUNTERACTS FIBRONECTIN FRAGMENT INDUCED UPREGULATION OF NITRIC OXIDE  by Chowdhury, T.T. et al.
S86 Poster Presentations
were obtained when each zone of AC was analysed separately
and also when data for MCP and MTP joints was analysed
individually.
Conclusions: The apparent linear increase in chondrocyte apop-
tosis at early stages of AC degradation (‘modified’ Mankin grades
0-3) suggests that this process may play a significant role in the
initiation of cartilage damage. This data therefore supports the
notion that cell death by apoptosis may be an important ae-
tiopathogenic mechanism in OA.
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Purpose: The importance of nitric oxide (•NO) as a key mediator
in the pathophysiology of osteoarthritis (OA) has been well docu-
mented. The underlying mechanism involves the induction of •NO
and prostaglandin E2 (PGE2) by pro-inflammatory cytokines, that
lead to the degradation of the extracellular matrix constituents.
Fibronectin is a component of the extracellular matrix. In OA,
fibronectin is degraded into small fragments and these degra-
dation products could play a major role in cartilage breakdown.
Recent studies have shown that fibronectin fragments (Fn-F)
enhance the release of •NO and/or matrix metalloproteinase
(MMP) enzymes. However, these studies focused primarily on
the pathways in the absence of mechanical stimuli. We have pre-
viously shown that dynamic compression counteracts •NO and
PGE2 release in the presence of IL-1β. The current study exam-
ines the biochemical changes observed by chondrocyte/agarose
constructs subjected to dynamic compression in the presence of
Fn-F.
Methods: Initial dose response studies were conducted under
free-swelling conditions in order to determine the appropriate
concentration of Fn-F for the mechanical loading studies. Chon-
drocyte/agarose constructs were cultured for 48 hours in radio-
labelled media containing 0, 0.01, 0.1, 1 or 10 μg ml-1 of the
heparin binding 40 kDa Fn-F, +/- 1 mM L-NIO (NOS inhibitor).
For the mechanical loading studies, constructs were subjected
to 15% dynamic compressive strain at 1 Hz frequency for 48
hours in media supplemented with 0 or 10 μg ml-1 Fn-F, +/- 1
mM 1400 W (iNOS inhibitor). Nitrite and PGE2 release, [3H]-
thymidine and 35SO4 incorporation were measured using well
established biochemical assays.
Results: Fn-F at concentrations of 0.1, 1 and 10 μg ml-1 in-
creased nitrite release when compared to control constructs (all
p<0.001). L-NIO downregulated nitrite release when constructs
were cultured with 10 μg.ml-1Fn-F (p<0.05). By contrast, Fn-F
did not significantly influence PGE2 release in the presence and
absence of L-NIO. [3H]-thymidine incorporation was downregu-
lated with 1 and 10 μg.ml-1 Fn-F when compared to control con-
structs (p<0.05 and p<0.001). 10 μg.ml-1 Fn-F inhibited 35SO4
incorporation when compared to control construct (p.0.001) and
this response was reversed by L-NIO (p<0.01).
In unstrained constructs, 10 μg.ml-1 Fn-F upregulated nitrite re-
lease when compared to control constructs (p<0.001). Dynamic
compression inhibited nitrite release in the absence and pres-
ence of Fn-F (both p<0.001) and this effect was abolished with
1400 W. Dynamic compression in the presence and absence of
Fn-F did not significantly influence PGE2 release (Fig. 2B). In
unstrained constructs, Fn-F and 1400 W increased PGE2 release
when compared to control constructs (p<0.01). This effect was
not influenced by dynamic compression. In the absence of Fn-F,
dynamic compression upregulated [3H]-thymidine (p<0.001) and
35SO4 incorporation (p<0.01). The upregulation of [3H]-thymidine
and 35SO4 incorporation by dynamic compression was abolished
with Fn-F and enhanced with 1400 W (p<0.001 and p<0.01,
respectively).
Conclusions: The current study demonstrates that Fn-F stim-
ulates •NO release and this effect could be abolished by me-
chanical load. PGE2 levels were not influenced by the presence
of Fn-F, suggesting alternative pathways which could activate
IL-1β and/or MMP expression. Thus, a suppression of •NO is
important in mediating the upregulation of cell proliferation and
proteoglycan synthesis in response to dynamic compression.
Further characterization of the mechanotransduction pathway in
the presence of inflammatory mediators may identify pharmaco-
logical targets for the treatment of OA.
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Purpose: Interleukin-1β (IL-1β) stimulated chondrocytes produce
a variety of mediators of cartilage degradation including matrix
metalloproteinases (MMPs) that play a pivotal role in joint de-
struction in osteoarthritis (OA). The objective of this study was to
characterize the high molecular weight (HMW) MMPs produced
by IL-1β-stimulated OA chondrocytes that are also found in the
synovial fluid of OA joints.
Methods: Chondrocytes were prepared by enzymatic digestion
of OA cartilage. Nearly confluent chondrocyte cultures were
serum-starved overnight and stimulated with IL-1β for different
time periods. Substrate-embedded enzymography and collagen
degradation assays were used to characterize the MMP activity
in chondrocyte conditioned media and also in OA synovial fluid.
Western immunoblotting and immunoprecipitation was used to
confirm the presence of specific MMP proteins. Chondrocyte
nucleofection with small interfering RNAs (siRNAs) was used
to knockdown MMP-9, MMP-13 and NGAL gene expression.
Quantitative RT-PCR was employed to quantify MMP and NGAL
mRNA expression. Cartilage explants were stained with Safranin-
O/Fast Green and proteoglycan and collagen degradation was
determined in the cell culture supernatant with metachromatic
dye assays.
Results: One of the HMW MMPs of ∼130-kDa found in OA
synovial fluid was a complex of MMP-9 and NGAL. Immunologi-
cal, biochemical and molecular biology approaches were used to
confirm this result. Western immunoblotting showed that OA syn-
ovial fluid contained high levels of NGAL, MMP-9, and MMP-13
